Adnexus Therapeutics , Inc.

Location:

100 Beaver StreetWalthamMassachusetts02453United States View Map

Revenue:

$11.6 Million

Employees:

58

SIC Codes:

2834

NAICS Codes:

325412

Phone:

(781) 891-3745

Fax:

(781) 891-3796
More

Description:

Adnexus Therapeutics is focused on generating vital medicines through the discovery, development, and commercialization of its broadly applicable new therapeutic class, Adnectins. Adnexus' lead product candidate, Angiocept (CT-322), is in Phase 1 clinical development in oncology in the United States. The company also has a pipeline of other Adnectin products in preclinical research across multiple therapeutic areas. Adnectins are designed and optimized using PROfusion, the company's patented protein design engine that uniquely enables rapid optimization of protein therapeutics. The company is funded by five leading venture capital firms: Atlas Venture, Flagship Ventures, HBM BioVentures, Polaris Venture Partners, and Venrock.

Read More

Competitors

Recently Updated profiles at this company

Nonclinical Research and Development

Browse ZoomInfo’s Directories